Objective
Neurotensin is a peptide whose receptor (SORT1) is linked to cardiovascular disease (CVD) development. We hypothesized concentrations of pro-neurotensin (pro-NT; stable pro-fragment of neurotensin) would predict incident CV events in community-based subjects.
Approach and Results
Blood samples from 3439 participants in the Framingham Heart Study (FHS) Offspring cohort (mean age 59.2 years, 47.1% male) were tested for pro-NT. Primary outcome of interest was incident hard CVD (myocardial infarction, stroke, and CV death); interaction between pro-NT concentration with sex, low density lipoprotein (LDL) concentrations or SORT1 single-nucleotide polymorphisms (SNP) was sought. At baseline, those in the highest log-pro-NT quartile were younger and heavier (P<0.001); across pro-NT quartiles, more prevalent hard CVD (from 3% to 7%; P<0.001) and diabetes mellitus (from 6% to 14; P<0.001) was present. In age and sex-adjusted models, log-pro-NT concentrations predicted incident hard CVD (hazard ratio [HR] = 1.24 per standard deviation [SD] change in log-pro-NT; 95% confidence intervals [CI] = 1.11–1.39; P<0.001), a finding that remained upon adjustment for standard CVD risk factors (HR 1.13; 95% CI = 1.01–1.27; P = 0.03). Elevated log-pro-NT concentrations were associated with shorter time to first event (P=0.02). We found no effect modification by sex, LDL concentration, or SORT1 SNPs. Concentrations of pro-NT were modestly associated with left ventricular mass and coronary artery calcium in these subjects.
Conclusions
Higher concentrations of pro-NT are associated with a greater risk of incident CV events in the community. This association did not vary according to sex, baseline LDL, or SORT1 genotype.